Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
FDA Grants Approval to ABRYSVO™, Pfizer's Vaccine for Preventing Respiratory Syncytial Virus (RSV) in Older Adults
Pfizer Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its vaccine called ABRYSVO™ (Respiratory Syncytial Virus Vaccine) to prevent lower respiratory tract disease caused by Respiratory Syncytial Virus (RSV) in individuals aged 60 and above. ABRYSVO is a unadjuvanted bivalent RSV prefusion F (RSVpreF) vaccine that contains two preF proteins selected to offer optimal protection against RSV A and B strains. The vaccine has demonstrated safety and efficacy....
FDA Accepts Satsuma Pharmaceuticals' 505(b) (2) NDA for STS101: A Promising Investigational Dihydroergotamine (DHE) Nasal Powder for Acute Migraine Treatment
Satsuma Pharmaceuticals, a development-stage biopharmaceutical company (Nasdaq: STSA), has announced that the U.S. Food and Drug Administration (FDA) has accepted its 505(b) (2) new drug application (NDA) for STS101. STS101 is a novel and investigational therapeutic product candidate aimed at treating acute migraines....
Sania Therapeutics Launches with a Mission to Advance Innovative Therapies for Neural Circuit Dysfunction
Sania Therapeutics has officially launched with a focus on developing genetic medicines to address neural circuit dysfunction. The company unveiled its suite of proprietary patented platforms at the American Society of Gene & Cell Therapy (ASGCT) conference....
Thermo Fisher Scientific Secures FDA Clearance for Immunoassays Advancing Preeclampsia Risk Assessment
Thermo Fisher Scientific, a leading company in the field of scientific solutions, has announced that the U.S. Food and Drug Administration (FDA) has granted clearance for their immunoassays aimed at aiding in the risk assessment of preeclampsia. This breakthrough designation makes the Thermo Scientific B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR immunoassays the first of their kind to receive FDA clearance for this purpose....
Novel Drug Delivery Approach to Treat Brain Tumors in Children
Researchers at Mount Sinai Health System and Memorial Sloan Kettering Cancer Centre have developed a new medication delivery technique that uses nanoparticles to deliver anti-cancer medicines to children with brain tumors in a more effective and focused manner....
GSK’s First RSV Vaccine for Older Adults Launched
The first respiratory syncytial virus (RSV) vaccine, adjuvanted, Arexvy, has been launched by GSK for preventing lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV)....
Pfizer Launches Novel Vaccine for IPD Prevention in Children
Pfizer has recently launched a groundbreaking vaccine called PREVNAR 20® (20-valent Pneumococcal Conjugate Vaccine) to combat invasive pneumococcal disease (IPD) in children. ...
Breakthrough Investigational Therapeutic for Influenza Immunotherapy
SAB Biotherapeutics has recently announced that the U.S. Food and Drug Administration (FDA) has awarded Breakthrough Therapy Designation (BTD) to their investigational therapeutic, SAB-176....
Radiopharm Theranostics Launches Innovative Pancreatic Cancer Technology
Radiopharm Theranostics has recently unveiled an innovative radiopharmaceutical technology called Ga68-Trivehexin (RAD 301). This ground-breaking drug is designed specifically for imaging patients with pancreatic ductal adenocarcinoma (PDAC)....
Genmab Launches Novel Drug for R/R DLBCL Treatment
Genmab A/S introduces EPKINLY™ (epcoritamab-bysp), the first and only T-cell engaging bispecific antibody for adult patients with R/R DLBCL, including DLBCL arising from indolent lymphoma and high-grade B‑cell lymphoma after multiple lines of therapy....
